PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $97.02 million. The enterprise value is $64.31 million.
| Market Cap | 97.02M |
| Enterprise Value | 64.31M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PDSB has 36.68 million shares outstanding. The number of shares has increased by 8.23% in one year.
| Shares Outstanding | 36.68M |
| Shares Change (YoY) | +8.23% |
| Shares Change (QoQ) | +2.43% |
| Owned by Insiders (%) | 3.67% |
| Owned by Institutions (%) | 22.95% |
| Float | 35.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.33, with a Debt / Equity ratio of 0.91.
| Current Ratio | 4.33 |
| Quick Ratio | n/a |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.04 |
Financial Efficiency
Return on equity (ROE) is -138.40% and return on invested capital (ROIC) is -86.12%.
| Return on Equity (ROE) | -138.40% |
| Return on Assets (ROA) | -69.00% |
| Return on Capital (ROIC) | -86.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.92% in the last 52 weeks. The beta is 1.72, so PDSB's price volatility has been higher than the market average.
| Beta (1Y) | 1.72 |
| 52-Week Price Change | -59.92% |
| 50-Day Moving Average | 4.63 |
| 200-Day Moving Average | 5.05 |
| Relative Strength Index (RSI) | 27.80 |
| Average Volume (30 Days) | 927,801 |
Short Selling Information
The latest short interest is 6.15 million, so 16.77% of the outstanding shares have been sold short.
| Short Interest | 6.15M |
| Short Previous Month | 5.51M |
| Short % of Shares Out | 16.77% |
| Short % of Float | 17.37% |
| Short Ratio (days to cover) | 4.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.05M |
| Pretax Income | -44.35M |
| Net Income | -42.94M |
| EBITDA | -42.87M |
| EBIT | -43.05M |
| Earnings Per Share (EPS) | -$1.39 |
Balance Sheet
The company has $56.56 million in cash and $23.85 million in debt, giving a net cash position of $32.71 million or $0.89 per share.
| Cash & Cash Equivalents | 56.56M |
| Total Debt | 23.85M |
| Net Cash | 32.71M |
| Net Cash Per Share | $0.89 |
| Equity / Book Value | 26.13M |
| Book Value Per Share | 0.71 |
| Working Capital | 45.43M |
Cash Flow
| Operating Cash Flow | -33.64M |
| Capital Expenditures | n/a |
| Free Cash Flow | -33.64M |
| FCF Per Share | -$1.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.23% |
| Shareholder Yield | -8.23% |
| Earnings Yield | -44.26% |
| FCF Yield | -34.67% |
Analyst Forecast
The average price target for PDSB is $17.33, which is 555.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.33 |
| Price Target Difference | 555.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |